Unjustified prescription drug increases on just eight commonly used medications led patients and health insurers nationwide to spend an additional $1.2 billion in 2022, a new report shows.
The report comes from the Institute for Clinical and Economic Review (ICER), a nonprofit that monitors the cost-effectiveness of medications. The organization aims to check for meaningful price increases for prescription drugs.





